Zineh I - Search Results

1

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization.

Khurana M, Vaidyanathan J, Marathe A, Mehrotra N, Sahajwalla CG, Zineh I, Jain L. Khurana M, et al. Among authors: zineh i. J Clin Pharmacol. 2015 Jun;55(6):647-56. doi: 10.1002/jcph.466. Epub 2015 Feb 16. J Clin Pharmacol. 2015. PMID: 25612234 Review.

2

Office of clinical pharmacology science day: a forum to stimulate innovation in clinical pharmacology.

Owen RP, Jain L, Zhang L, Zineh I. Owen RP, et al. Among authors: zineh i. Clin Pharmacol Ther. 2013 Jun;93(6):471-3. doi: 10.1038/clpt.2013.33. Clin Pharmacol Ther. 2013. PMID: 23689212

3

Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.

Momper JD, Heinrichs MT, Krudys K, Griebel D, Kumar S, Kim I, Mehrotra N, Mulberg AE, Garimella N, Nelson R, Reaman G, Sinha V, Yao L, Zineh I, Burckart G, Sachs H, Mulugeta Y. Momper JD, et al. Among authors: zineh i. J Clin Pharmacol. 2020 Jun;60(6):775-784. doi: 10.1002/jcph.1577. Epub 2020 Jan 22. J Clin Pharmacol. 2020. PMID: 31967340

4

Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance.

Zhao L, Li Z, Fang L, Kim MJ, Nallani SC, Sahajwalla CG, Calderon SN, Roca RA, Feng K, Zineh I, Lionberger R. Zhao L, et al. Among authors: zineh i. EClinicalMedicine. 2021 Sep 16;41:101135. doi: 10.1016/j.eclinm.2021.101135. eCollection 2021 Nov. EClinicalMedicine. 2021. PMID: 34585126 Free PMC article.

5

Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of Abuse.

Nallani SC, Li W, Calderon SN, Fields E, Roca RA, Xu Y, Zhao L, Fang L, Sahajwalla CG, Zineh I. Nallani SC, et al. Among authors: zineh i. Pain Med. 2022 Jul 1;23(7):1311-1322. doi: 10.1093/pm/pnab339. Pain Med. 2022. PMID: 34865125

6

Physiologically based pharmacokinetic modeling: from regulatory science to regulatory policy.

Sinha V, Zhao P, Huang SM, Zineh I. Sinha V, et al. Among authors: zineh i. Clin Pharmacol Ther. 2014 May;95(5):478-80. doi: 10.1038/clpt.2014.46. Clin Pharmacol Ther. 2014. PMID: 24747236

7

Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.

Sahre MD, Milligan L, Madabushi R, Graham RA, Reynolds KS, Terzic A, Benjamin J, Burckart GJ, Huang SM, Schuck R, Thompson AM, Zineh I. Sahre MD, et al. Among authors: zineh i. Clin Pharmacol Ther. 2021 Aug;110(2):285-288. doi: 10.1002/cpt.2151. Epub 2021 Feb 16. Clin Pharmacol Ther. 2021. PMID: 33411946

8

Clinical pharmacology and the catalysis of regulatory science: opportunities for the advancement of drug development and evaluation.

Zineh I, Woodcock J. Zineh I, et al. Clin Pharmacol Ther. 2013 Jun;93(6):515-25. doi: 10.1038/clpt.2013.32. Epub 2013 Feb 12. Clin Pharmacol Ther. 2013. PMID: 23571772

9

Improving the tools of clinical pharmacology: Goals for 2017 and beyond.

Zineh I, Abernethy D, Hop C, Bello A, McClellan MB, Daniel GW, Romine MH. Zineh I, et al. Clin Pharmacol Ther. 2017 Jan;101(1):22-24. doi: 10.1002/cpt.530. Epub 2016 Nov 17. Clin Pharmacol Ther. 2017. PMID: 27727433

10

Toward greater insights on pharmacokinetics and exposure-response relationships for therapeutic biologics in oncology drug development.

Wang Y, Booth B, Rahman A, Kim G, Huang SM, Zineh I. Wang Y, et al. Among authors: zineh i. Clin Pharmacol Ther. 2017 May;101(5):582-584. doi: 10.1002/cpt.628. Epub 2017 Mar 15. Clin Pharmacol Ther. 2017. PMID: 28090657 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters